122 related articles for article (PubMed ID: 32023696)
1. [Risk analysis for hypervascular transformation of precancerous lesion of hepatocellular carcinoma].
Li XM; Liu C; Wang J; Xia F; Cai P
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):31-36. PubMed ID: 32023696
[No Abstract] [Full Text] [Related]
2. Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation.
Kim YS; Song JS; Lee HK; Han YM
Eur Radiol; 2016 Oct; 26(10):3728-36. PubMed ID: 26670318
[TBL] [Abstract][Full Text] [Related]
3. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
4. Newly developed hypervascular hepatocellular carcinoma during follow-up periods in patients with chronic liver disease: observation in serial gadoxetic acid-enhanced MRI.
Yamamoto A; Ito K; Tamada T; Higaki A; Kanki A; Sato T; Tanimoto D
AJR Am J Roentgenol; 2013 Jun; 200(6):1254-60. PubMed ID: 23701061
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetate Disodium-Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology.
Channual S; Tan N; Siripongsakun S; Lassman C; Lu DS; Raman SS
AJR Am J Roentgenol; 2015 Sep; 205(3):546-53. PubMed ID: 26295640
[TBL] [Abstract][Full Text] [Related]
6. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma.
Hyodo T; Murakami T; Imai Y; Okada M; Hori M; Kagawa Y; Kogita S; Kumano S; Kudo M; Mochizuki T
Radiology; 2013 Feb; 266(2):480-90. PubMed ID: 23362095
[TBL] [Abstract][Full Text] [Related]
7. [Research progress in imaging characteristics of precancerous nodules in hepatocellular carcinoma cells].
Gao F; Cai P; Liu C; Xia F; Wang J
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):9-13. PubMed ID: 32023691
[TBL] [Abstract][Full Text] [Related]
8. Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.
Park HJ; Lee TY; Kim SY; Kim MJ; Singal AG; Lee SJ; Won HJ; Byun JH; Lim YS
Eur Radiol; 2022 Aug; 32(8):5064-5074. PubMed ID: 35229195
[TBL] [Abstract][Full Text] [Related]
9. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
10. Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging.
Sugimoto K; Moriyasu F; Shiraishi J; Saito K; Taira J; Saguchi T; Imai Y
Eur Radiol; 2012 Jun; 22(6):1205-13. PubMed ID: 22270142
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of small hepatocellular nodules detected only at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging as hypointensity in cirrhosis or chronic hepatitis.
Higaki A; Ito K; Tamada T; Sone T; Kanki A; Noda Y; Yasokawa K; Yamamoto A
Eur Radiol; 2014 Oct; 24(10):2476-81. PubMed ID: 25030460
[TBL] [Abstract][Full Text] [Related]
12. Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.
Briani C; Di Pietropaolo M; Marignani M; Carbonetti F; Begini P; David V; Iannicelli E
J Gastrointest Cancer; 2018 Sep; 49(3):302-310. PubMed ID: 28547117
[TBL] [Abstract][Full Text] [Related]
13. Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.
Sano K; Ichikawa T; Motosugi U; Ichikawa S; Morisaka H; Enomoto N; Matsuda M; Fujii H
Eur Radiol; 2017 Feb; 27(2):518-525. PubMed ID: 27255397
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging.
Song KD; Rhim H; Lee MW; Kim YS; Kang TW
Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759
[TBL] [Abstract][Full Text] [Related]
15. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
16. Hypervascular Transformation of Hypovascular Hypointense Nodules in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: A Systematic Review and Meta-Analysis.
Suh CH; Kim KW; Pyo J; Lee J; Kim SY; Park SH
AJR Am J Roentgenol; 2017 Oct; 209(4):781-789. PubMed ID: 28742376
[TBL] [Abstract][Full Text] [Related]
17. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
18. Hypovascular hypointense nodules in hepatobiliary phase without T2 hyperintensity: long-term outcomes and added value of DWI in predicting hypervascular transformation.
Yang HJ; Song JS; Choi EJ; Choi H; Yang JD; Moon WS
Clin Imaging; 2018; 50():123-129. PubMed ID: 29353716
[TBL] [Abstract][Full Text] [Related]
19. Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma.
Hwang JA; Kang TW; Kim YK; Kim SH; Paik YH; Ha SY; Kim S
Eur J Radiol; 2017 Oct; 95():362-369. PubMed ID: 28987693
[TBL] [Abstract][Full Text] [Related]
20. Progression of Hepatic Hypovascular Nodules with Hypointensity in the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in Hepatocellular Carcinoma Cases.
Saitoh T; Sato S; Yazaki T; Tobita H; Miyake T; Ishihara S; Katsube T; Kitagaki H; Kinoshita Y
Intern Med; 2018 Jan; 57(2):165-171. PubMed ID: 29033416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
